Healthcare -
Biotechnology - NASDAQ - US
$ 4.4186
-5.79 %
$ 168 M
Market Cap
-2.76
P/E
OBIO - GROSS PROFIT
Gross Profit OBIO - Orchestra BioMed Holdings, Inc.
2.57 M
LAST VALUE
115.03%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR